Cargando…

Molecular phenotypes reveal heterogeneous engraftments of patient-derived hepatocellular carcinoma xenografts

OBJECTIVE: Patient-derived xenograft (PDX) models provide a promising preclinical platform for hepatocellular carcinoma (HCC). However, the molecular features associated with successful engraftment of PDX models have not been revealed. METHODS: HCC tumor samples from 76 patients were implanted in im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuo, Jianyong, Lu, Di, Wang, Jianguo, Lian, Zhengxing, Zhang, Jiali, Li, Huihui, Cen, Beini, Wei, Xuyong, Wei, Qiang, Xie, Haiyang, Xu, Xiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435819/ https://www.ncbi.nlm.nih.gov/pubmed/34584372 http://dx.doi.org/10.21147/j.issn.1000-9604.2021.04.04

Ejemplares similares

The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib
por: Zhuo, Jianyong, et al.
Publicado: (2021)

The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular Carcinoma
por: Lu, Di, et al.
Publicado: (2020)

The ongoing trends of patient‐derived xenograft models in oncology
por: Zhuo, Jianyong, et al.
Publicado: (2020)

Single‐cell profiling reveals distinct immune phenotypes that contribute to ischaemia‐reperfusion injury after steatotic liver transplantation
por: Yang, Xinyu, et al.
Publicado: (2021)

CR6-interacting factor 1 inhibits invasiveness by suppressing TGF-β-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
por: Zhuang, Runzhou, et al.
Publicado: (2017)

High Expression of Human AugminComplex Submit 3 Indicates Poor Prognosis and Associates with Tumor Progression in Hepatocellular Carcinoma
por: Zhang, Xuanyu, et al.
Publicado: (2019)

Interleukin-2 inducible T-cell kinase: a potential prognostic biomarker and tumor microenvironment remodeling indicator for hepatocellular carcinoma
por: Pan, Binhua, et al.
Publicado: (2021)

Molecular dissection of engraftment in a xenograft model of myelodysplastic syndromes
por: Meunier, Mathieu, et al.
Publicado: (2018)

Prognostic value of patient‐derived xenograft engraftment in pediatric sarcomas
por: Castillo‐Ecija, Helena, et al.
Publicado: (2021)

Proteomics‐based identification of the role of osteosarcoma amplified‐9 in hepatocellular carcinoma recurrence
por: Wei, Xuyong, et al.
Publicado: (2022)

Patient-derived xenograft models in hepatopancreatobiliary cancer
por: Pan, Binhua, et al.
Publicado: (2022)

Successful Secondary Engraftment of Pancreatic Ductal Adenocarcinoma and Cholangiocarcinoma Patient-Derived Xenografts After Previous Failed Primary Engraftment()
por: Hernandez, Matthew C., et al.
Publicado: (2018)

LEPREL1 Expression in Human Hepatocellular Carcinoma and Its Suppressor Role on Cell Proliferation
por: Wang, Jianguo, et al.
Publicado: (2013)

CD46–ADC Reduces the Engraftment of Multiple Myeloma Patient-Derived Xenografts
por: VanWyngarden, Michael J., et al.
Publicado: (2023)

Diagnostic Value of Preoperative Needle Biopsy for Tumor Grading Assessment in Hepatocellular Carcinoma
por: Wang, Lijun, et al.
Publicado: (2015)

Characterization of genome-wide TFCP2 targets in hepatocellular carcinoma: implication of targets FN1 and TJP1 in metastasis
por: Xu, Xiao, et al.
Publicado: (2015)

Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts
por: Woo, Xing Yi, et al.
Publicado: (2021)

The circFASN/miR-33a pathway participates in tacrolimus-induced dysregulation of hepatic triglyceride homeostasis
por: Zhang, Chenzhi, et al.
Publicado: (2020)

Salinomycin-Loaded Small-Molecule Nanoprodrugs Enhance Anticancer Activity in Hepatocellular Carcinoma
por: Wang, Jianguo, et al.
Publicado: (2020)

Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy
por: Xu, Shengjun, et al.
Publicado: (2021)

Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1
por: Ling, Sunbin, et al.
Publicado: (2017)

Correlation between tumor engraftment in patient-derived xenograft models and clinical outcomes in colorectal cancer patients
por: Oh, Bo Young, et al.
Publicado: (2015)

Optimized Xenograft Protocol for Chronic Lymphocytic Leukemia Results in High Engraftment Efficiency for All CLL Subgroups
por: Decker, Sarah, et al.
Publicado: (2019)

Author Correction: Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts
por: Woo, Xing Yi, et al.
Publicado: (2021)

Immunologically “cold” triple negative breast cancers engraft at a higher rate in patient derived xenografts
por: Petrosyan, Varduhi, et al.
Publicado: (2022)

ATRA sensitized the response of hepatocellular carcinoma to Sorafenib by downregulation of p21-activated kinase 1
por: Wang, Kai, et al.
Publicado: (2023)

Metabolomic biomarkers for the diagnosis and post-transplant outcomes of AFP negative hepatocellular carcinoma
por: Lin, Zuyuan, et al.
Publicado: (2023)

Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder Cancers
por: Skowron, K. B., et al.
Publicado: (2016)

Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival
por: Pergolini, Ilaria, et al.
Publicado: (2017)

Use of Transabdominal Ultrasound for the detection of intra-peritoneal tumor engraftment and growth in mouse xenografts of epithelial ovarian cancer
por: Chambers, Laura M., et al.
Publicado: (2020)

Development of a Novel Prognostic Nomogram for High Model for End-Stage Liver Disease Score Recipients Following Deceased Donor Liver Transplantation
por: Yang, Mengfan, et al.
Publicado: (2022)

The Engrafting of Nerves
Publicado: (1845)

Establishment of patient-derived xenografts from patients with gastrointestinal stromal tumors: analysis of clinicopathological characteristics related to engraftment success
por: Na, Young-Soon, et al.
Publicado: (2020)

Heterogeneous matrix stiffness regulates the cancer stem-like cell phenotype in hepatocellular carcinoma
por: Wei, Jiayun, et al.
Publicado: (2022)

Stratified Analysis of Survival Benefit for ABO-incompatible Deceased-donor Liver Transplantation: Multicenter Propensity Score-matched Study
por: Yang, Mengfan, et al.
Publicado: (2023)

Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models
por: Rosato, Roberto R., et al.
Publicado: (2018)

miRNA profiles in livers with different mass deficits after partial hepatectomy and miR-106b~25 cluster accelerating hepatocyte proliferation in rats
por: Xu, Xiao, et al.
Publicado: (2016)

The Molecular Subtype of Adult Acute Lymphoblastic Leukemia Samples Determines the Engraftment Site and Proliferation Kinetics in Patient-Derived Xenograft Models
por: Richter, Anna, et al.
Publicado: (2022)

Prediction of Early Recurrence of Hepatocellular Carcinoma in Patients with Cirrhosis Who Had Received Deceased Donor Liver Transplantation: A Multicenter Study
por: Al-Ameri, Abdulahad Abdulrab Mohammed, et al.
Publicado: (2019)

Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma – The Changing Tides
por: Khan, Abdul Rehman, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6d4r322brr0h0s8kiqsa77035p